---
figid: PMC11036500__WJG-30-1911-g003
pmcid: PMC11036500
image_filename: WJG-30-1911-g003.jpg
figure_link: /pmc/articles/PMC11036500/figure/F3/
number: Figure 3
figure_title: ''
caption: 'Differential expression metabolites in serum metabolomics of pAAV-HBV1.2
  replication mice treated with Liuweiwuling Tablet. A: Volcanogram of differentially
  expressed metabolites (DEMs); B: Heat map of DEMs between High-dose Liuweiwuling
  Tablet group (HG)/control group (CG); C: Kyoto Encyclopedia of Genes and Genomes
  pathway enrichment for the DEMs between HG/CG; D: Receiver operating characteristic
  curve validation of the DEMs between HG/CG; E: Heat map of eight key DEMs between
  HG/CG; F: Potential apoptosis-related metabolic pathways of Liuweiwuling Tablet
  against hepatitis B virus. LWWL: Liuweiwuling Tablet; HG: High-dose LWWL group;
  LG: Low-dose LWWL group; CG: Control group; TG: Tenofovir disoproxil fumarate group.'
article_title: Inhibition of hepatitis B virus via selective apoptosis modulation
  by Chinese patent medicine Liuweiwuling Tablet.
citation: Fei-Lin Ge, et al. World J Gastroenterol. 2024 Apr 7;30(13):1911-1925.
year: '2024'

doi: 10.3748/wjg.v30.i13.1911
journal_title: World Journal of Gastroenterology
journal_nlm_ta: World J Gastroenterol
publisher_name: Baishideng Publishing Group Inc

keywords:
- Hepatitis B virus
- Chinese patent medicine
- Antiviral activity
- Antiviral mechanism
- Selective apoptosis

---
